TNDM - タンデム・ダイアベティス・ケア (Tandem Diabetes Care Inc.)

TNDMのニュース

   Tandem Diabetes Care Inc Shares Near 52-Week High - Market Mover  2021/12/26 08:40:48 Kwhen Finance
Tandem Diabetes Care Inc (TNDM) shares closed today at 1.0% below its 52 week high of $153.40, giving the company a market cap of $9B. The stock is currently up 58.7% year-to-date, up 61.7% over the past 12 months, and up 6500.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 48.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 1858.8% The company's stock price performance over the past 12 months beats the peer average by 1009.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -716.8% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Tandem Diabetes Care Inc Shares Near 52-Week High - Market Mover  2021/12/25 01:48:52 Kwhen Finance
Tandem Diabetes Care Inc (TNDM) shares closed today at 1.0% below its 52 week high of $153.40, giving the company a market cap of $9B. The stock is currently up 58.7% year-to-date, up 62.3% over the past 12 months, and up 6500.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 48.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 1858.8% The company's stock price performance over the past 12 months beats the peer average by 1142.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -716.8% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   New Insight On Tandem Diabetes Care Inc. (TNDM)  2021/12/24 14:30:00 Stocks Register
Tandem Diabetes Care Inc. (NASDAQ:TNDM) concluded the trading at $151.80 on Thursday, December 23 with a fall of -0.67% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $152.82 and 5Y monthly beta was reading 0.25 with its price kept floating in … New Insight On Tandem Diabetes Care Inc. (TNDM) Read More »
   Tandem Diabetes Care, Inc. (NASDAQ:TNDM) EVP Sells $1,731,000.00 in Stock  2021/12/20 09:32:42 Transcript Daily
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) EVP David B. Berger sold 12,000 shares of the companys stock in a transaction that occurred on Wednesday, December 15th. The stock was sold at an average price of $144.25, for a total transaction of $1,731,000.00. The sale was disclosed in a document filed with the SEC, which is available []
   36 Stocks Moving In Wednesday''s Mid-Day Session  2021/12/15 17:40:46 Benzinga
Gainers Nxt-ID, Inc. (NASDAQ: NXTD ) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal emergency response systems to Federal, State and Local government purchasers. Biofrontera Inc. (NASDAQ: BFRI ) shares climbed 27.6% to $7.02 after Benchmark initiated coverage on the stock with a Buy rating and announced a $11 price target. CMC Materials, Inc. (NASDAQ: CCMP ) surged 25.9% to $183.74 after the company announced it will be acquired by Entegris for $6.5 billion in cash and stock. Insignia Systems, Inc. (NASDAQ: ISIG ) surged 21.2% to $20.18. Gemini Therapeutics, Inc. (NASDAQ: GMTX ) gained 21% to $2.94 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and a $20 price target. mCloud Technologies Corp. (NASDAQ: MCLD ) jumped 17.2% to $4.6405 after the company signed a cloud agreement with Virtual Vision to host AssetCare customers in Saudi Arabia. Vir Biotechnology, Inc. (NASDAQ: VIR ) gained 15.2% to $53.03 after the company announced new preclinical data demonstrating the impact of the significant antigenic shift of the new SARS-CoV-2 Omicron variant.
   Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $140.00  2021/11/07 12:08:41 Dakota Financial News
Tandem Diabetes Care (NASDAQ:TNDM) had its price target hoisted by Piper Sandler from $132.00 to $140.00 in a research report released on Thursday, The Fly reports. Piper Sandler currently has an overweight rating on the medical device companys stock. Piper Sandler also issued estimates for Tandem Diabetes Cares Q4 2021 earnings at $0.17 EPS, FY2021 []
   Tandem Diabetes Care (NASDAQ:TNDM) Announces Earnings Results, Beats Estimates By $0.01 EPS  2021/11/06 17:04:41 Dakota Financial News
Tandem Diabetes Care (NASDAQ:TNDM) issued its quarterly earnings data on Wednesday. The medical device company reported $0.09 earnings per share (EPS) for the quarter, beating the Zacks consensus estimate of $0.08 by $0.01, MarketWatch Earnings reports. Tandem Diabetes Care had a net margin of 1.08% and a return on equity of 3.68%. During the same []
   Piper Sandler Increases Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $140.00  2021/11/06 15:28:42 Dakota Financial News
Tandem Diabetes Care (NASDAQ:TNDM) had its target price boosted by equities research analysts at Piper Sandler from $132.00 to $140.00 in a report released on Thursday, The Fly reports. The firm currently has an overweight rating on the medical device companys stock. Piper Sandlers target price would indicate a potential upside of 7.16% from the []
   Steward Partners Investment Advisory LLC Sells 300 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)  2021/11/06 09:10:41 Transcript Daily
Steward Partners Investment Advisory LLC trimmed its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) by 41.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 420 shares of the medical device company’s stock after selling 300 shares […]
   Tandem Diabetes Care Inc (TNDM) EVP & CHIEF FINANCIAL OFFICER Leigh Vosseller Sold $1. ...  2021/11/05 23:15:02 GuruFocus
Related Stocks: TNDM ,
   Artificial Pancreas Devices Systems Market 2021: Detailed Analysis of Current Industry Figures with Forecasts Growth By 2028| Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed, and Others.  2021/09/01 10:27:44 OpenPR
The global artificial pancreas device systems market exhibited strong growth during 2015-2021. Looking forward, IMARC Group expects the market to grow at a CAGR of 12% during 2021-2028. Artificial pancreas device system are the devices that closely copy the glucose regulating function
   Digital Diabetes Device Market Size 2021 by Product Sales, Revenue, Price, Market Share, Growth Opportunity and Forecast to 2027 Research Report I Top key players-Lifescan, Roche, Medtronic, Ascensia Diabetes Care, TANDEM Diabetes Care, DEXCOM, Social D  2021/08/30 11:15:37 OpenPR
Digital diabetes devices are the executives'' arrangements are cell phone associated diabetes the board gadgets and programming stages utilized by patients experiencing Type 1, Type 2, and gestational diabetes. Clinical experts likewise utilize these answers to oversee diabetes. Get sample copy
   Beyond Type 1 Named an Official Charity Partner of the 2021 TCS New York City Marathon  2021/08/25 19:00:00 Benzinga
SAN CARLOS, Calif., Aug. 25, 2021 /PRNewswire/ -- Global diabetes nonprofit Beyond Type 1 was named an Official Charity Partner for the 2021 TCS New York City Marathon, taking place on November 7 . This year serves as the 50th celebratory running of the marathon. Beyond Type 1 will be among the more than 400 official charity partners providing thousands of runners the opportunity to run in the world''s most popular marathon. Presented by Dexcom and Tandem Diabetes Care , this year''s Beyond Type Run Team is made up of 50 runners living with Type 1 diabetes (T1D) from 23 states and five countries. These individuals are raising awareness and funds for Type 1 diabetes as ambassadors for Beyond Type 1, showcasing how they live beyond their diagnoses and supporting crucial efforts and programs for others affected by this condition. "We''re thrilled to get the chance to assemble another incredible and inspiring team showing people with diabetes everywhere that anything is possible with this condition," said Beyond Type 1 CEO Thom Scher . "We''re grateful for support from Dexcom and Tandem Diabetes Care and the opportunity to connect and inspire community members through Beyond Type Run." Beyond Type 1 has taken three prior teams to the TCS New York City Marathon in 2017, 2018 and 2019 with a goal of inspiring individuals affected by diabetes all over the world.
   Consonance Capital Management LP Buys Tandem Diabetes Care Inc, Globus Medical Inc, Protagonist ...  2021/08/18 16:38:17 GuruFocus
Related Stocks: GMED , PTGX , LEGN , VSTM , TNDM , SRPT , CHFW.U , SLN , JYAC , RACB , MGNX , MRTX , TPTX , ARVN , IOVA , ATRA ,
   Algert Coldiron Investors Llc Buys Herbalife Nutrition, Carter''s Inc, Tandem Diabetes Care Inc, ...  2021/08/16 23:38:16 GuruFocus
Related Stocks: HLF , TNDM , AMZN , UNVR , SLGN , TNET , CRI , BA , EQIX , CPRT , GOOG , ANTM , WFC , V , INTC , VLO , ROST , BWXT ,

calendar